Vijaya Diagnostic Centre Limited (NSE:VIJAYA)

Market Cap	95.56B
Revenue (ttm)	7.00B
Net Income (ttm)	1.43B
Shares Out	102.64M
EPS (ttm)	13.92
PE Ratio	66.89
Forward PE	54.10
Dividend	1.00 (0.11%)
Ex-Dividend Date	Aug 30, 2024

Volume	763,706
Average Volume	580,014
Open	935.70
Previous Close	931.10
Day's Range	885.00 - 939.40
52-Week Range	730.00 - 1,275.00
Beta	-0.10
RSI	37.48
Earnings Date	May 8, 2025

About Vijaya Diagnostic Centre

Vijaya Diagnostic Centre Limited engages in the provision of diagnostic services for patients in India. It offers laboratory services, including clinical pathology, microbiology, haematology, serology, histopathology, cytogenetics, biochemistry, molecular diagnostics, CT scan, magnetic resonance imaging (MRI) scan, ultrasound, X-ray, cardiology, gastroenterology, nuclear medicine and PET/CT, and MRI-3T services. The company also provides health checkups and home sample collection services. Vijaya Diagnostic Centre Limited was founded in 1981 an...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1981
• Employees: 2,053
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: VIJAYA

Financial Performance

In 2024, Vijaya Diagnostic Centre's revenue was 7.00 billion, an increase of 27.73% compared to the previous year's 5.48 billion. Earnings were 1.43 billion, an increase of 20.41%.